Analyzing the RNA-Based Therapeutics Market region dynamics reveals that North America currently leads the world in both research and commercialization. This dominance is due to a dense concentration of biotech companies in hubs like Boston and San Francisco, supported by robust NIH funding and a favorable regulatory environment. However, Europe is quickly closing the gap, with...